These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1975882)

  • 21. Genetic factors influencing the outcome of early arthritis--the role of sulphoxidation status.
    Emery P; Bradley H; Arthur V; Tunn E; Waring R
    Br J Rheumatol; 1992 Jul; 31(7):449-51. PubMed ID: 1628166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A proposed mechanism for chlorpromazine jaundice--defective hepatic sulphoxidation combined with rapid hydroxylation.
    Watson RG; Olomu A; Clements D; Waring RH; Mitchell S; Elias E
    J Hepatol; 1988 Aug; 7(1):72-8. PubMed ID: 3183354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re-evaluation of the metabolism of carbocisteine in a British white population.
    Gregory WL; James OF; Turner I; Meese CO; Idle JR
    Pharmacogenetics; 1993 Oct; 3(5):270-4. PubMed ID: 8287066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenylalanine 4-monooxygenase and the role of endobiotic metabolism enzymes in xenobiotic biotransformation.
    Steventon GB; Mitchell SC
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1213-21. PubMed ID: 19653802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. S-carboxymethyl-L-cysteine and it (R/S)-S-oxides in beagle dog plasma and hepatic cytosol.
    Panagopoulos P; Mitchell SC; Steventon GB
    Xenobiotica; 2015; 45(12):1047-53. PubMed ID: 26068525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Influence of cysteine on bioavailability of theophylline (author's transl)].
    Albin H; Vinçon G; Taytard A; Freour P; Dangoumau J
    Therapie; 1981; 36(5):525-31. PubMed ID: 7323990
    [No Abstract]   [Full Text] [Related]  

  • 27. High pressure liquid chromatographic determination of carbocisteine in human plasma and urine.
    Bron J
    Pharm Weekbl Sci; 1986 Apr; 8(2):134-8. PubMed ID: 3086832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antithyroid action of carbocisteine.
    Wiersinga WM
    Br Med J (Clin Res Ed); 1986 Jul; 293(6539):106. PubMed ID: 3089410
    [No Abstract]   [Full Text] [Related]  

  • 29. Poor sulphoxidation ability in patients with food sensitivity.
    Scadding GK; Ayesh R; Brostoff J; Mitchell SC; Waring RH; Smith RL
    BMJ; 1988 Jul; 297(6641):105-7. PubMed ID: 3408928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenetics of the S-oxidation of S-carboxymethyl-L-cysteine.
    Waring RH
    Drug Metabol Drug Interact; 1988; 6(3-4):253-63. PubMed ID: 3078290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term oral carbocisteine therapy in patients with chronic bronchitis. A double blind trial with placebo control.
    Grillage M; Barnard-Jones K
    Br J Clin Pract; 1985 Oct; 39(10):395-8. PubMed ID: 3907681
    [No Abstract]   [Full Text] [Related]  

  • 32. Determination of the sulphoxide metabolites of S-carboxymethyl-L-cysteine by high-performance liquid chromatography with electrochemical detection.
    Woolfson AD; Millership JS; Karim EF
    Analyst; 1987 Oct; 112(10):1421-5. PubMed ID: 3434821
    [No Abstract]   [Full Text] [Related]  

  • 33. Syntheses of metabolites of S-carboxymethyl-L-cysteine and S-methyl-L-cysteine and of some isotopically labelled (2H, 13C) analogues.
    Meese CO; Specht D; Hofmann U
    Arch Pharm (Weinheim); 1990 Dec; 323(12):957-65. PubMed ID: 2096798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased prevalence of poor sulphoxidation in patients with rheumatoid arthritis: effect of changes in the acute phase response and second line drug treatment.
    Emery P; Bradley H; Gough A; Arthur V; Jubb R; Waring R
    Ann Rheum Dis; 1992 Mar; 51(3):318-20. PubMed ID: 1575574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The metabolism and elimination of S-carboxymethyl-L-cysteine in man.
    Waring RH; Mitchell SC
    Drug Metab Dispos; 1982; 10(1):61-2. PubMed ID: 6124385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of S-carboxymethyl-L-cysteine for otitis media with effusion.
    Steventon GB; Mitchell SC
    Ear Nose Throat J; 2006 May; 85(5):296-7. PubMed ID: 16771015
    [No Abstract]   [Full Text] [Related]  

  • 37. The metabolism of S-carboxyalkylcysteines in man.
    Rogers KM; Barnsley EA
    Xenobiotica; 1977 Jul; 7(7):409-14. PubMed ID: 888445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. S-carboxymethyl-L-cysteine.
    Mitchell SC; Steventon GB
    Drug Metab Rev; 2012 May; 44(2):129-47. PubMed ID: 22497630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic factors influencing the outcome of early arthritis--the role of sulphoxidation status.
    de Vries N; van Riel PC; Russel FG; van de Putte LB
    Br J Rheumatol; 1993 Feb; 32(2):170-2. PubMed ID: 8428236
    [No Abstract]   [Full Text] [Related]  

  • 40. Mechanism of S-(carboxymethylthio)cysteine cleavage by rat liver cystathionine-gamma-lyase.
    Yao K; Kinuta M; Watanabe Y
    Physiol Chem Phys; 1978; 10(6):569-73. PubMed ID: 38467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.